CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	382K 336K 317K 289K 541K 36.69M 545K 3.8M 1.47M 18.67M 1.43M 1.4M 60.76M	P/E 2014	-2.3x	P/E 2015	-2.17x
Enterprise Value	539K 474K 447K 408K 762K 51.71M 768K 5.36M 2.08M 26.32M 2.02M 1.98M 85.64M	EV / Sales 2014	-	EV / Sales 2015	-
Free-Float	97.49%	Yield 2014 *	-	Yield 2015	-

10/09/21	Cardiogenics Holdings Inc Announces A Record Date Change for Its Dividend Distribution	CI
04/09/21	CardioGenics Holdings Inc. Announces License Agreement	CI
02/11/15	CardioGenics Holdings Inc completed the acquisition of substantially all of the assets of Plasticap Inc.	CI
05/10/15	CardioGenics Holdings Inc entered into a non-binding letter of intent to acquire substantially all of the assets of Plasticap Inc.	CI
13/01/15	CardioGenics Holdings Inc. Appoints Karim Murabet as Director	CI
27/09/13	CardioGenics Holdings Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013	CI
21/08/13	CardioGenics Holdings Inc Announces Commencement of Beta-Site Testing	CI
05/06/13	CardioGenics Holdings Inc Announces Internal Review Board Approval for Beta-Site Testing	CI
03/06/13	CardioGenics Holdings Inc announced that it has received $0.66 million in funding.	CI
31/05/13	CardioGenics Holdings Inc announced that it expects to receive $1.5 million in funding.	CI
01/03/13	CardioGenics Holdings Inc. Announces Demise of Director, Alexander D. G. Reid	CI
27/02/13	CardioGenics Holdings Inc. announced that it expects to receive $1 million in funding.	CI
17/04/12	CardioGenics Holdings Inc has Changed its Ticker to CGNH from CGNHE	CI

29/09/21	UPDATED: CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
10/09/21	CARDIOGENICS : ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
04/09/21	CARDIOGENICS : ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION	AQ
04/11/15	CardioGenics : Enters Into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap	MW
05/10/15	CardioGenics : Enters Into Binding Letter of Intent to Acquire Assets of Ontario-Based Plasticap	MW

Manager	Title	Age	Since
Yahia A. Gawad CEO	Chief Executive Officer	68	27/10/2009
James A. Essex DFI	Director of Finance/CFO	78	16/06/2010
Linda J. Sterling IRC	Investor Relations Contact	65	-

Director	Title	Age	Since
Yahia A. Gawad BRD	Director/Board Member	68	06/04/2011
Julian Neil Tabatznik CHM	Chairman	76	16/06/2010
Linda J. Sterling BRD	Director/Board Member	65	16/06/2010

CardioGenics Holdings Inc Stock Other OTC

Stocks

CGNH

US14160X2036

Medical Equipment, Supplies & Distribution

Valuation: CardioGenics Holdings Inc

Latest news: CardioGenics Holdings Inc

Press Releases: CardioGenics Holdings Inc

Quotes and Performance

Managers and Directors: CardioGenics Holdings Inc

Diagnostic & Testing Substances

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARDIOGENICS HOLDINGS INC	-35.19%	+110.24%	-	-	142
GUARDANT HEALTH, INC.	+0.08%	-3.63%	+205.96%	+580.49%	23.68B
BIOMÉRIEUX	-0.19%	+7.54%	-31.25%	-15.03%	10.32B
10X GENOMICS, INC.	+11.23%	+9.28%	+597.43%	+103.41%	10.96B
CARIS LIFE SCIENCES, INC.	+1.96%	+4.37%	+6.01%	-	9.12B
LANTHEUS HOLDINGS, INC.	-0.25%	-1.07%	+87.34%	+61.31%	6.51B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-2.43%	-2.75%	-28.20%	-22.97%	5.58B
DIASORIN S.P.A.	-0.48%	+2.01%	+5.37%	-9.12%	4.42B
ANDON HEALTH CO., LTD.	-2.61%	+2.10%	+58.76%	+64.39%	3.85B
AUTOBIO DIAGNOSTICS CO., LTD.	-2.29%	+4.63%	-15.75%	-27.88%	2.86B
Average	-3.02%	+2.26%	+98.41%	+91.83%	8.59B
Weighted average by Cap.	+1.38%	+1.69%	+152.28%	+221.77%

	2014	2015
Net sales	-	-
Net income	-2.68M -2.36M -2.22M -2.03M -3.79M -257M -3.82M -26.67M -10.33M -131M -10.06M -9.84M -426M	-1.92M -1.69M -1.59M -1.45M -2.71M -184M -2.73M -19.07M -7.39M -93.62M -7.2M -7.04M -305M
Net Debt	132K 116K 110K 100K 187K 12.69M 189K 1.32M 510K 6.46M 497K 486K 21.02M	157K 138K 130K 118K 221K 15.02M 223K 1.56M 603K 7.65M 588K 575K 24.88M